Shares in ReNerve (ASX: RNV) surged as much 100% on news that its NervAlign® Nerve Cuff is approved for use across the US Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems, representing a significant endorsement of ReNerve’s NervAlign® nerve cuff technology. The approval allows the NervAlign® Nerve Cuff to be used across the DoD's 51 military hospitals and 424 clinics, as well as VA's 170 medical centres and nearly 1200 outpatient facilities, providing ready access to ~9.5 million patients across both healthcare systems who may benefit from its use. Covered by Stockhead.

SHAPE Australia (ASX:SHA) announced its acquisition of Arden Group, a retail fit out and facilities maintenance specialist. This move aligns with SHAPE's strategy to diversify its capabilities. The acquisition broadens SHAPE’s offering into retail multi-site fit outs and maintenance, sectors it has not traditionally serviced. The acquisition is expected to be earnings accretive in its first full year of ownership, broaden SHAPE’s margin profile and deliver $6.2 million in pro forma FY26 EBITDA.

Bell Potter initiated coverage on WA renewable energy developer Frontier Energy (ASX: FHE) with a BUY (Spec) rating and a $0.50/sh price target, nearly 70% upside on its current price. Bells identified upside from Frontier’s project location, WA’s energy shortage and rising electricity prices, Frontier’s secured reserve capacity credits and its ability to scale the project with more battery capacity.

Lycopodium (ASX: LYL) released updated FY26 guidance and outlook at its AGM yesterday, highlighting expected revenue between ~$390 to $410 million and NPAT between ~$40 to $44 million. The company noted strong operational momentum to start the year as it continues to advance key projects and expand its global footprint, supported by ongoing demand for its high-quality engineering and project delivery expertise. Lycopodium also released its AGM Presentation and 2025 Sustainability Report.

Sparc Technologies (ASX: SPN) commenced its first collaborative coatings project with Dulux Australia, incorporating ecosparc® into a Dulux Protective Coating system for the Cape Jaffa Lighthouse - Sparc’s fifth real-world ecosparc® application with major coatings manufacturers and a key step in its commercialisation pathway. The Company also received a $981K FY25 R&D tax refund, providing non-dilutive funding to advance ecosparc® development and broader R&D programs. Covered in Australian Manufacturing.

Chimeric Therapeutics (ASX: CHM) reported continued positive results from its CHM CDH17 Phase 1/2 clinical trial, with 75% of evaluable patients achieving disease control at 28 days and 100% of those at Dose Level 2 maintaining stable disease. One colorectal cancer patient continues to show stable disease nearly a year post-treatment with no additional therapy. The data confirm the potential of CHM CDH17, a third-generation CAR-T therapy targeting the CDH17 biomarker, in treating advanced gastrointestinal cancers.

Looking for leverage to the nuclear renaissance? Uranium play Lotus Resources (ASX: LOT) takes the yellowcake, writes Barry FitzGerald in Stockhead. "The long-term uranium price hit $US85/lb in October, which is its highest level since 2012 and there is literally weekly news confirming that a full-blown nuclear power renaissance is underway," he says. Barry discusses the latest research on the company from Macquarie, Canaccord, Ord Minnett and Petra Capital – "the implied share price upside is there all right."

Hazer (ASX: HZR) secured a paid engineering study with UK-based EnergyPathways plc, together with KBR, to develop a hydrogen and graphite production facility in England. The agreement marks the first commercial project under the Hazer–KBR Alliance and will form part of EnergyPathways’ nationally significant MESH Project, representing the first large-scale (20,000 tpa) deployment of the Hazer Process. It also becomes Hazer’s second revenue-generating project, alongside FortisBC in Canada, further strengthening commercial momentum and global reach.

Aurum Resources (ASX: AUE) new high-grade hits at its Boundiali Project in Côte d’Ivoire prompted Petra Capital to reaffirm a BUY rating and lift its price target to $1.40/share, a 169% upside to the current $0.52 share price. Standout intercept: 18m @ 3.9g/t gold, outside the 2.41Moz MRE. With 12 rigs turning and a PFS due Mar Q’26, AUE is fully funded with ~$24m cash + ~$21m in Montage shares.

With Kairos Minerals (ASX: KAI) kicking off a 60-hole, 10,000m drilling program on an extension of its 1.4Moz Mt York Gold Project in the Pilbara after signing a mineral rights agreement with PLS, Petra Capital reaffirmed its BUY rating and upgraded its target price to $0.09/sh, representing more than 150% upside to KAI’s share price.

METALS, MINING AND ENERGY

Many Peaks Minerals (ASX: MPK) extended gold mineralisation in all directions along strike in final diamond drill (DD) results from its ~21,000m campaign on the Ouarigue prospect, part of the Company’s flagship Ferké Gold Project in Côte d’Ivoire. The final 16 DD holes returned results including 35.7m @ 3.81g/t gold from 512.3m. Covered by MiningNews.

Aurum Resources (ASX: AUE) hit 5m @ 11.07 g/t gold within 18m @ 3.93 g/t gold outside current Mineral Resources at the BDT2 target at its Boundiali Gold Project in Côte d’Ivoire. Aurum reported latest results from its ongoing 100,000m CY2025 drill program at Boundiali, designed to grow and increase confidence in Mineral Resources. A MRE update for Boundiali is expected early CY2026. Covered by Business News.

Krakatoa Resources (ASX: KTA) advanced in-adit drilling at its Zopkhito Antimony-Gold Project in Georgia, intersecting antimony in several of the completed drill holes. Krakatoa has completed 18 diamond drill holes and nine underground in-adit core sampling holes, with initial results expected Q4 2025 - Q1 2026. Covered by Proactive.

Power Minerals (ASX: PNN) reported further high-grade niobium and rare earth results from shallow auger drilling at the Santa Anna Project in Brazil, including 1m at 1.36% Nb₂O₅ and 17m at 6,895ppm TREO from surface. The program continues to confirm extensive mineralisation within the Santa Anna Alkaline Complex, with consistent grades supporting potential for a high-grade discovery. A 10,000m reverse circulation drilling campaign will commence this month to extend the mineralised footprint and deliver the project’s first Mineral Resource Estimate, with initial 2,000m of drilling expected to conclude in Q1 2026. Covered by Stockhead and Australian Resources & Investment.

Axel REE (ASX: AXL) commenced a gallium and rare earth Mineral Resource Estimate for Area B at its Caladão Project, which is advancing as a potential district scale, Tier-1 primary gallium and rare earth elements (REE) discovery. The Area B MRE is expected to be completed by the end of 2025 and will build on the substantial existing resources at Area A, which hosts 233Mt @ 2,133ppm TREO and 100Mt @ 42ppm gallium.

Iltani Resources (ASX: ILT) received initial assay results from the Orient VTEM drilling. The 10-hole RC drilling program targeting shallow VTEM anomalies provided promising results from ORR128 including 1m @ 317.8 g/t Ag Eq. from 34m and 9m @ 68.6 g/t Ag Eq. from 54m. These results confirm the value of VTEM and demonstrate the potential to materially increase the Orient MRE, with the hole 450m north of Orient East in an area with no previous drilling.

Kairos Minerals (ASX: KAI) received outstanding results from latest drilling at Main Hill and Gossan Hill at its Mt York Gold Project. The 14 holes of shallow and deeper extensional drilling included 67m @ 1.92 g/t Au from 140m at Gossan Hill and 50m @ 1.10 g/t Au from 235m at Main Hill, highlighting the wide zones of higher-grade gold mineralisation. Kairos has completed 89 holes this year, with more results pending, as it works towards a MRE update in Q1 CY2026.

Argent Minerals (ASX: ARD) is ramping up drilling to target multiple high-priority targets at its Kempfield Silver Project and Trunkey Creek Gold Project in NSW. The campaign includes more than 45 reverse circulation and diamond drill holes for approximately 3,200m targeting both precious and base metals, with a focus on gold and silver. Covered by Stockhead.

Charger Metals (ASX: CHR) is preparing to commence a six-hole gold focused reverse circulation drill program at the Richard Gold Prospect at its Lake Johnston Project. Historic drilling at the Richard Gold Prospect returned several strong gold intercepts including 5m @ 7.15 g/t Au from 24m.   Charger commenced the first of four  drill holes into a lithium niobium soil anomaly at the Mt Gordon Prospect at Lake Johnston. The anomaly (>10ppm Nb) covers an area of 1.8km by 1.7km with results up to 21.4ppm Nb with coincident gravity and magnetic anomalies.

Middle Island Resources (ASX: MDI) assay results from its initial channel sampling program at the historic Bobija Mine area, has confirmed significant precious and base metal mineralisation. This marks the Company’s first major exploration campaign at Bobija. The Phase 1 Reverse Circulation drilling program at Bobija is now complete, with assay results pending. Covered by mining.com.au and Business News.

Evergreen Lithium (ASX: EG1) executed a binding option agreement with Metallium Limited (MTM) to acquire up to a 100% interest in tenements comprising the Mt Monger Gold Project.  The Acquisition complements Evergreen's existing gold portfolio in WA's Goldfields, enhancing exploration upside in a prolific region.

Golden Dragon (ASX: GDR) announced Reverse Circulation (RC) drilling is set to commence at the Behring Bore area at advanced gold target Coodardy. Drilling is planned to start before the end of the month with an estimated start date of 24 November.

Rokeby Resources (ASX: RKB) confirmed multiple new high-grade gold and antimony targets across the Hurricane Project in northern Queensland, following the latest round of field sampling and structural mapping. Follow-up work is underway to further refine drill targets and define the extent of high-grade mineralisation across newly identified prospects.

Certified overlimit analysis from previous results reported have returned exceptional caesium grades up to 28.3% Cs₂O at Perpetual Resources’ (ASX: PEC) Morro Grande prospect at Igrejina - confirming its potential to host a significant caesium occurrence. Hear Executive Chairman Julian Babrczy discuss.

BIOTECH

BPH Global (ASX: BP8) continues to advance its marine biotechnology platform, today announcing R&D on seaweed-based male vitality formulations in partnership with Gaia Mariculture Pte Ltd. This program leverages marine bioactives known for their rich antioxidant, amino acid, and polysaccharide content — supporting circulation, energy, and overall wellbeing.

Radiopharm Theranostics (ASX: RAD) announced the completion of enrollment for the second cohort of patients in the Phase 1 dose escalation trial of 177Lu-RAD204 in PD-L1 positive advanced cancers, including non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), triple-negative breast cancer (TNBC), cutaneous melanoma, head and neck squamous cell carcinoma (HNSCC) and endometrial cancer. Covered by Biotech Dispatch.

INDUSTRIALS

ECS Botanics (ASX: ECS) announced a $1.95 million capital raise, strongly supported by new and existing institutional and sophisticated investors. Funds raised will accelerate product innovation, support investment in inventory and expand ECS's international distribution footprint. Covered by Cannabiz.

TECHNOLOGY

Etherstack Plc (ASX:ESK) released upgraded guidance, expecting record FY25 (31 December year-end) revenue of US$9.6 –10.1m , a ~62% increase on FY24, with ore than US$2m positive operating cashflow and a US$40m order book from deals in the US and UK. The Company provided FY26 guidance forecasts of US$16.2–17.5m revenue, driven by the doubling of MCX/IWF sales and new CaaS recurring streams scaling to FY28.

Iondrive Limited (ASX: ION) has launched a solar panel recycling program targeting the high-purity recovery of silver and silicon from end-of-life photovoltaic cells, securing feedstock in Australia and Taiwan and progressing structured supply discussions in Europe. The initiative is designed to leverage Iondrive’s DES pilot plant under construction to establish a scalable, low-emission recovery pathway for high-value materials. 

Pathkey.AI (ASX: PKY) announced a new Master Collaboration Agreement with Armstrong Clinical, a Melbourne-based consultancy specialising in early-phase clinical study design, development strategy and regulatory planning. Covered by The Market Bull, Clinical Trials Arena, BioPharma Dispatch, BioTech Dispatch, Yahoo Finance and Finimize.

Rubicon Water (ASX: RWL) has continued to strengthen its position in Europe, signing a new contract in Italy’s Torinese region for a value of €730,000 (approximately A$1.3 million). The agreement adds to a series of recent wins across Italy, where Rubicon has now secured five significant projects this financial year with a combined value of around A$4.5 million.

CORPORATE NEWS

Ionic Rare Earths (ASX: IXR) signed a non-binding Memorandum of Understanding (MOU) with Missouri-based US Strategic Metals (USSM), a vertically integrated, multi-metallic critical minerals platform, at an official ceremony held at the Australian Embassy in Washington, D.C., highlighting the strong corporate commitment to supporting the U.S.- Australia critical minerals partnership.

Aureka (ASX: AKA) divested its interest in the Tandarra Project for $1.3 million, aligning with its strategic focus on advancing the Irvine Gold Project and St Arnaud Comstock Project in Victoria.

Proceeds will fund ongoing diamond drilling and land access activities at Irvine, where recent assays returned up to 183 g/t Au — the highest since discovery.

Imricor (ASX: IMR) announced Aldo Denti has joined its Board of Directors. With more than 30 years of global experience in the medical device industry, Aldo brings a wealth of expertise that will be instrumental as Imricor advances into its next phase of global commercialisation.

Chariot Corporation (ASX: CC9) commenced trading on the OTCQB Market in the United States under the ticker “CHRTF”. The secondary listing represents a significant milestone in the Company’s strategy to broaden its U.S. investor base and enhance access for North American institutional and retail investors.

Neurotech International (ASX: NTI) received a $4.73 million R&D tax incentive refund from the Australian Government for the 2025 financial year. The refund, part of the national R&D tax incentive program offering up to a 48.5% refundable offset, will support the continued clinical development of Neurotech’s therapies targeting paediatric neurological disorders, alongside general working capital.

Kalamazoo Resources (ASX: KZR) appointed highly respected exploration geologist Ben Ackerman as Exploration Director. Ben brings more than 25 years of gold and copper exploration experience, having held the role of APAC Regional Exploration Manager for Newcrest and Newmont. Covered by Mining.com.au

Arovella Therapeutics (ASX: ALA) appointed Dr Andrew Nash as Non-Executive Director. Dr Nash has over 35 years of practical drug development experience and executive leadership in the biotech and pharmaceutical sector, most recently with Australia’s largest and most successful pharmaceutical company, CSL. Covered by Biotech Dispatch

Proteomics International’s (ASX: PIQ) cash reserves were further strengthened by the receipt of $2.2 million in research and development tax incentive for the 2024-25 financial year. Proteomics International’s business model sees the Company pursue ground-breaking R&D with blue-sky potential in next generation diagnostic tests using its disruptive Promarker® technology platform. This R&D is also supported by revenue generated from providing sophisticated analytical services to the biopharmaceutical and life science industry. Covered by Bulls N’ Bears.

Larvotto Resources (ASX: LRV) Managing Director Ron Heeks chatted with S&P Global about the global antimony demand and the strategic importance of the Hillgrove Antimony-Gold Project.

Kalamazoo Resources (ASX: KZR) Executive Chairman Luke Reinehr spoke to Kerry Stevenson following the release of the Scoping Study for the Mt Olympus open pit deposit at its Ashburton Gold Project, WA. Luke also shared insights with Shae Russell from Mining.com.au.

Many Peaks Minerals (ASX: MPK) Managing Director Travis Schwertfeger spoke with SmithWeekly Research, providing an update on the Ferké Gold Project - covering the drilling progress, recent results, pending assays and upcoming plans to expand mineralisation. He also outlined what’s ahead for the Odienné, Baga, and Oumé projects.

Iondrive Limited (ASX: ION) CEO Dr Ebbe Dommisse joined Andrew Musgrave from ASX Briefs to discuss how Iondrive’s DES platform enables selective, low-footprint recovery of critical minerals across magnets, battery black mass, e-waste and end-of-life solar panels, supporting scalable urban-mining opportunities.

Krakatoa Resources (ASX: KTA) Executive Chairman Colin Locke spoke to Proactive following the identification of multiple occurrences of visible antimony from diamond drilling and underground sampling at its Zopkhito Project.

Larvotto Resources (ASX: LRV) Managing Director Ron Heeks discussed recent activity at the Hillgrove Antimony-Gold Project including Pybar being appointed as underground development contractor with Shae Russell from Mining.com.au.

Sparc Technologies (ASX: SPN) Investor Webinar: MD Nick O’Loughlin outlines progress toward ecosparc® commercialisation in protective steel coatings.

Youtube | Spotify

Built to Deliver: Engineering Lycopodium’s Winning Global Formula

In this episode of Vantage Point, we’re joined by Peter De Leo, Managing Director and CEO of Lycopodium Limited (ASX: LYL) — a leading global engineering and project delivery organisation with an established track record across the resources, infrastructure and industrial processes industries.

Peter discusses how Lycopodium continues to deliver strong performance through disciplined project execution, a solutions-driven culture and long-standing client partnerships. He shares insights into the company’s evolving role in an era of energy transition and sustainability, the growing demand for engineering expertise in battery and critical minerals projects, and the leadership principles that underpin Lycopodium’s reputation for reliability and innovation.

It’s a thoughtful conversation that explores how Lycopodium is positioning for long-term success while staying true to the values that have defined its three-decade history as it continues pursuit of its global expansion strategy.